These significant improvements in sensitivity for early stage cases and for all cases were found in ROC analysis (Fig. 1C, D, further demonstrating the complementarity and added value of HE4, HE4 Ag-AAb, and OPN to serum CA125 for detection of ovarian cancer). This evidence concerns the gene WFDC2 and ovarian cancer.